Inhibitors of protein tyrosine kinases
作者： David W Fry , Alexander J Bridges
DOI: 10.1016/0958-1669(95)80109-X
关键词:
摘要: The description in the past year of several novel protein tyrosine kinase inhibitors, which exhibit dramatic improvements potency and specificity over earlier agents, will be considered a major turning point field. These compounds appear to have necessary pharmacological properties finally allow clarification whether suppression specific kinases is therapeutic benefit certain disease states.
elsevier.com
sci-hub.se 参考文章(36)
David R. Kaplan, Archibald Perkins, Deborah K. Morrison, Signal transduction by receptor tyrosine kinases Oncogenes and Tumor Suppressor Genes in Human Malignancies. ,vol. 63, pp. 265- 279 ,(1993) , 10.1007/978-1-4615-3088-6_13
David P. Hajjar, Kenneth B. Pomerantz, Signal transduction in atherosclerosis: integration of cytokines and the eicosanoid network. The FASEB Journal. ,vol. 6, pp. 2933- 2941 ,(1992) , 10.1096/FASEBJ.6.11.1644257
Gordon W Rewcastle, William A Denny, Alexander J Bridges, Hairong Zhou, Donna R Cody, Amy McMichael, David W Fry, None, Tyrosine kinase inhibitors. 5. Synthesis and structure-activity relationships for 4-[(phenylmethyl)amino]- and 4-(phenylamino)quinazolines as potent adenosine 5'-triphosphate binding site inhibitors of the tyrosine kinase domain of the epidermal growth factor receptor. Journal of Medicinal Chemistry. ,vol. 38, pp. 3482- 3487 ,(1995) , 10.1021/JM00018A008
Deborah L. Cadena, Gordon N. Gill, Receptor tyrosine kinases. The FASEB Journal. ,vol. 6, pp. 2332- 2337 ,(1992) , 10.1096/FASEBJ.6.6.1312047
Walter H.J. Ward, Peter N. Cook, Anthony M. Slater, D.Huw Davies, Geoffrey A. Holdgate, Leslie R'. Green, Epidermal growth factor receptor tyrosine kinase: Investigation of catalytic mechanism, structure-based searching and discovery of a potent inhibitor Biochemical Pharmacology. ,vol. 48, pp. 659- 666 ,(1994) , 10.1016/0006-2952(94)90042-6
Lars Rönnstrand, Alexander Levitzki, Johannes Waltenberger, Annette Böhmer, Carl-Henrik Heldin, Marina Kovalenko, Aviv Gazit, Frank-D. Böhmer, Charlotte Rorsman, Selective Platelet-derived Growth Factor Receptor Kinase Blockers Reverse sis-Transformation Cancer Research. ,vol. 54, pp. 6106- 6114 ,(1994)
R Vassar, E Fuchs, Transgenic mice provide new insights into the role of TGF-alpha during epidermal development and differentiation. Genes & Development. ,vol. 5, pp. 714- 727 ,(1991) , 10.1101/GAD.5.5.714
Simon P Langdon, John F Smyth, Inhibition of cell signalling pathways Cancer Treatment Reviews. ,vol. 21, pp. 65- 89 ,(1995) , 10.1016/0305-7372(95)90011-X
Uwe Trinks, Elisabeth Buchdunger, Pascal Furet, Wilhelm Kump, Helmut Mett, Thomas Meyer, Marcel Mueller, Urs Regenass, Greti Rihs, Dianilinophthalimides : potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinase Journal of Medicinal Chemistry. ,vol. 37, pp. 1015- 1027 ,(1994) , 10.1021/JM00033A019
Huixiong Chen, Janine Boiziau, Fabienne Parker, Patrick Mailliet, Alain Commercon, Bruno Tocque, Jean-Bernard Le Pecq, Bernard-Pierre Roques, Christiane Garbay, Structure-activity relationships in a series of 5-[(2,5-dihydroxybenzyl)amino]salicylate inhibitors of EGF-receptor-associated tyrosine kinase: importance of additional hydrophobic aromatic interactions. Journal of Medicinal Chemistry. ,vol. 37, pp. 845- 859 ,(1994) , 10.1021/JM00032A020